Six peptides. One FDA panel vote.


Guys, BPC-157, MOTS-c, TB-500. Compounds people have been using off-label for years just got a nod from an FDA advisory committee for the compounding pharmacy list.
This isn't small. It's the system catching up to what biohackers were already doing.
The panel vote was narrow though. Some are calling it a win for personal health freedom. Others are warning it opens the door to more misuse.
Regulation always lags behind what people are actually doing with their own bodies, right?
Peptides went from underground longevity forums to an FDA hearing room in a few years.
What gets legitimized next?
post-image
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pinned